+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antibodies"

Autoimmune Monoclonal Antibody Global Market Report 2025 - Product Thumbnail Image

Autoimmune Monoclonal Antibody Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
Endometriosis- Pipeline Insight, 2025 - Product Thumbnail Image

Endometriosis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Celiac Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Celiac Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Pemphigus Vulgaris - Pipeline Insight, 2025 - Product Thumbnail Image

Pemphigus Vulgaris - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Vitiligo - Pipeline Insight, 2025 - Product Thumbnail Image

Vitiligo - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Chronic Spontaneous Urticaria - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Sjogren's Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Sjogren's Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Graves' Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Graves' Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 60 Pages
  • Global
From
Nasal Polyps - Pipeline Insight, 2025 - Product Thumbnail Image

Nasal Polyps - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 60 Pages
  • Global
From
From
Lupus Nephritis - Pipeline Insight, 2025 - Product Thumbnail Image

Lupus Nephritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors- Pipeline Insight, 2025 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 150 Pages
  • Global
From
Crohns Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Crohns Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
Urticaria- Pipeline Insight, 2025 - Product Thumbnail Image

Urticaria- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Acute Graft-versus-Host Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Acute Graft-versus-Host Disease- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Microbiome Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Microbiome Disease- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 280 Pages
  • Global
From
Crohn's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Crohn's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
Loading Indicator

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments. The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more